CA3020562A1 - Acides carboxyliques pour le traitement/la prevention d'une maladie de la peau - Google Patents

Acides carboxyliques pour le traitement/la prevention d'une maladie de la peau Download PDF

Info

Publication number
CA3020562A1
CA3020562A1 CA3020562A CA3020562A CA3020562A1 CA 3020562 A1 CA3020562 A1 CA 3020562A1 CA 3020562 A CA3020562 A CA 3020562A CA 3020562 A CA3020562 A CA 3020562A CA 3020562 A1 CA3020562 A1 CA 3020562A1
Authority
CA
Canada
Prior art keywords
skin
carboxylic acid
pharmaceutical composition
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3020562A
Other languages
English (en)
Inventor
Bettina ERNST
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proponent Biotech GmbH
Original Assignee
Proponent Biotech GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proponent Biotech GmbH filed Critical Proponent Biotech GmbH
Publication of CA3020562A1 publication Critical patent/CA3020562A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition pharmaceutique comprenant un acide carboxylique ou un sel de qualité pharmaceutique de ce dernier en tant que principe actif destinée à être utilisée dans le traitement et/ou la prévention d'une maladie de la peau. L'invention concerne également un procédé de traitement et/ou de prévention d'une maladie de la peau d'un patient, le procédé comprenant l'administration d'une quantité efficace d'un acide carboxylique ou d'un de qualité pharmaceutique de ce dernier à un patient en ayant besoin. En outre, l'invention concerne des utilisations cosmétiques d'une composition comprenant un acide carboxylique ou un sel de ce dernier pour réduire la rougeur de la peau, des lésions cutanées, des rides, des impuretés ou des irrégularités de la peau. En outre, la présente invention concerne une composition pharmaceutique comprenant comme principe actif un acide carboxylique ou un sel de qualité pharmaceutique de ce dernier, destiné à être utilisée pour améliorer la fonction barrière de la peau, la composition pharmaceutique étant administrée à un nourrisson et un procédé pour traiter et/ou prévenir une maladie de la peau d'un patient, le procédé comprenant l'administration d'une quantité efficace d'un acide carboxylique ou d'un sel de qualité pharmaceutique de ce dernier à un patient en ayant besoin.
CA3020562A 2016-05-17 2017-05-17 Acides carboxyliques pour le traitement/la prevention d'une maladie de la peau Abandoned CA3020562A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16169883 2016-05-17
EP16169883.2 2016-05-17
PCT/EP2017/061826 WO2017198701A1 (fr) 2016-05-17 2017-05-17 Acides carboxyliques pour le traitement/la prévention d'une maladie de la peau

Publications (1)

Publication Number Publication Date
CA3020562A1 true CA3020562A1 (fr) 2017-11-23

Family

ID=56014857

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3020562A Abandoned CA3020562A1 (fr) 2016-05-17 2017-05-17 Acides carboxyliques pour le traitement/la prevention d'une maladie de la peau

Country Status (13)

Country Link
US (1) US20200360317A1 (fr)
EP (1) EP3458042A1 (fr)
JP (1) JP2019516796A (fr)
KR (1) KR20190008235A (fr)
CN (1) CN109152753A (fr)
AU (1) AU2017266725A1 (fr)
BR (1) BR112018072164A2 (fr)
CA (1) CA3020562A1 (fr)
CL (1) CL2018003268A1 (fr)
MX (1) MX2018013477A (fr)
RU (1) RU2018143562A (fr)
SG (1) SG11201807911TA (fr)
WO (1) WO2017198701A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116194073A (zh) 2020-07-21 2023-05-30 化美有限责任公司 二酯化妆品制剂及其用途
WO2023170597A1 (fr) * 2022-03-08 2023-09-14 Sila S.P.A. Composition topique pour le traitement de lésions ou d'états inflammatoires cutanés ou de pathologies proctologiques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1163107A (zh) * 1996-04-19 1997-10-29 迟经惠 顽癣治疗液
IL136461A0 (en) * 1997-12-23 2001-06-14 Schering Corp Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
US20030064081A1 (en) * 2001-10-01 2003-04-03 Morgan William H. Topical anti-pruritic composition
JPWO2008096730A1 (ja) * 2007-02-09 2010-05-20 国立大学法人名古屋大学 抗炎症剤及びその用途
CN101380317B (zh) * 2007-09-07 2010-12-08 英属开曼群岛商安盛开发药物股份有限公司 减缓搔痒症的药学组合物
WO2012131069A1 (fr) * 2011-03-31 2012-10-04 Proponent Biotech Gmbh Acides gras à chaîne courte et leurs dérivés à utiliser dans le traitement de troubles immunogènes
ES2748632T3 (es) * 2012-10-03 2020-03-17 Proponent Biotech Gmbh Composición farmacéutica que comprende ácido propiónico para uso en el tratamiento de infecciones víricas

Also Published As

Publication number Publication date
AU2017266725A1 (en) 2018-10-04
BR112018072164A2 (pt) 2019-02-12
EP3458042A1 (fr) 2019-03-27
KR20190008235A (ko) 2019-01-23
US20200360317A1 (en) 2020-11-19
JP2019516796A (ja) 2019-06-20
CN109152753A (zh) 2019-01-04
RU2018143562A (ru) 2020-06-17
SG11201807911TA (en) 2018-10-30
WO2017198701A1 (fr) 2017-11-23
CL2018003268A1 (es) 2019-02-22
MX2018013477A (es) 2019-02-28

Similar Documents

Publication Publication Date Title
US20080207737A1 (en) Methods for the Treatment of Hyperhidrosis
US20070166273A1 (en) Skin treatment educational kit
US11497718B2 (en) Use of tapinarof for the treatment of atopic dermatitis
JP2000512996A (ja) 皮膚感作および刺激の予防および治療措置
WO1996023522A1 (fr) Traitement de la neuropathie diabetique
US20080242729A1 (en) Rxr Antagonists in the Treatment of Inflammatory Diseases
US20200360317A1 (en) Carboxylic acids for treating/preventing a skin disease
JP6185575B2 (ja) 皮膚炎症性疾患の治療方法
CN112891242A (zh) 一种用于祛斑美白抗炎的组合物及其应用
US20190160030A1 (en) Carboxylic acids for early childhood application
EP3476394A1 (fr) Compositions pour le traitement de stries et d'ulcères d'origine ischémique
JP3689137B2 (ja) アレルギー性皮膚疾患治療用外用剤
CN114173790A (zh) 一种包含6-重氮-5-氧代-l-正亮氨酸的用于治疗炎症皮肤疾病的药物组合物
JP3830963B2 (ja) 乾癬治療
KR20200126882A (ko) 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물
RU2426540C1 (ru) Противовоспалительное и противоаллергическое лекарственное средство и фармацевтическая композиция на его основе
US20220062308A1 (en) Methods and compositions for treating rosacea
JP2002308775A (ja) 外用組成物
GB2616294A (en) Composition for use
Gel Pr CLINDOXYL ADV Gel
Guria et al. A CASE REPORT ON MORPHEA PROFUNDA WITH HYPOTHYRODISM
Todd et al. Non-pharmacological treatment modalities for atopic dermatitis: CME-article
WO2023168004A1 (fr) Formulation topique destinée à diminuer l'inflammation ou la rougeur de la peau
Becker Management of perianal dermatoses
CN115803007A (zh) 厄洛替尼在治疗儿童角化病中的局部应用

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20220301